IT1281876B1 - Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. - Google Patents
Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci.Info
- Publication number
- IT1281876B1 IT1281876B1 IT95PD000089A ITPD950089A IT1281876B1 IT 1281876 B1 IT1281876 B1 IT 1281876B1 IT 95PD000089 A IT95PD000089 A IT 95PD000089A IT PD950089 A ITPD950089 A IT PD950089A IT 1281876 B1 IT1281876 B1 IT 1281876B1
- Authority
- IT
- Italy
- Prior art keywords
- matrixes
- drugs
- preparation
- hyaluronic acid
- controlled release
- Prior art date
Links
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 title 1
- 238000013270 controlled release Methods 0.000 title 1
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 229920002674 hyaluronan Polymers 0.000 title 1
- 229960003160 hyaluronic acid Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95PD000089A IT1281876B1 (it) | 1995-05-10 | 1995-05-10 | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
| AU58945/96A AU5894596A (en) | 1995-05-10 | 1996-05-08 | A dicarboxylic acid hemiester or hemiamide with a pharmacolo gically active compound and with hyaluronic acid or with a h yaluronic acid ester, a process for its preparation and a co ntrolled release medicament containing this derivative |
| PCT/EP1996/001980 WO1996035721A1 (en) | 1995-05-10 | 1996-05-08 | A dicarboxylic acid hemiester or hemiamide with a pharmacologically active compound and with hyaluronic acid or with a hyaluronic acid ester, a process for its preparation and a controlled release medicament containing this derivative |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT95PD000089A IT1281876B1 (it) | 1995-05-10 | 1995-05-10 | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| ITPD950089A0 ITPD950089A0 (it) | 1995-05-10 |
| ITPD950089A1 ITPD950089A1 (it) | 1996-11-10 |
| IT1281876B1 true IT1281876B1 (it) | 1998-03-03 |
Family
ID=11391039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT95PD000089A IT1281876B1 (it) | 1995-05-10 | 1995-05-10 | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. |
Country Status (3)
| Country | Link |
|---|---|
| AU (1) | AU5894596A (it) |
| IT (1) | IT1281876B1 (it) |
| WO (1) | WO1996035721A1 (it) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6254853B1 (en) * | 1998-05-08 | 2001-07-03 | Vyrex Corporation | Water soluble pro-drugs of propofol |
| AU752280C (en) * | 1998-05-20 | 2005-03-03 | Chugai Seiyaku Kabushiki Kaisha | Conjugate of therapeutic agent for joint disease and hyaluronic acid. |
| ITPD980169A1 (it) * | 1998-07-06 | 2000-01-06 | Fidia Advanced Biopolymers Srl | Ammidi dell'acido ialuronico e dei suoi derivati e processo per la loro preparazione. |
| RU2390529C2 (ru) * | 2004-01-07 | 2010-05-27 | Сейкагаку Корпорейшн | Производное гиалуроновой кислоты и содержащее его лекарственное средство |
| ITPD20050056A1 (it) | 2005-03-02 | 2006-09-03 | Fidia Farmaceutici | Derivati ammidici del'acido ialuronico in osteoartrosi |
| IE20060049A1 (en) * | 2006-01-25 | 2007-08-08 | Eurand Pharmaceuticals Ltd | A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents |
| IE20070900A1 (en) * | 2007-12-12 | 2009-06-24 | Eurand Pharmaceuticals Ltd | New anticancer conjugates |
| IT1391251B1 (it) * | 2008-10-15 | 2011-12-01 | Innovative Nutrition & Pharma Srl | Composizione per il trattamento delle patologie articolari |
| US8759322B2 (en) | 2008-11-05 | 2014-06-24 | National University Corporation Tokyo Medical And Dental University | Hyaluronic acid derivative and pharmaceutical composition thereof |
| ES2665254T3 (es) * | 2011-07-12 | 2018-04-25 | Holy Stone Healthcare Co., Ltd. | Composiciones que comprenden ácido hialurónico para tratamiento y prevención de enfermedades relacionadas con las mucosas |
| CN104603156B (zh) * | 2012-09-05 | 2016-10-26 | 中外制药株式会社 | 引入有氨基酸和甾基的透明质酸衍生物 |
| US10675354B2 (en) | 2013-07-10 | 2020-06-09 | Seikagaku Corporation | Glycosaminoglycan derivative and method for producing same |
| WO2015005458A1 (ja) * | 2013-07-10 | 2015-01-15 | 生化学工業株式会社 | グリコサミノグリカン誘導体及びその製造方法 |
| GB2518405A (en) * | 2013-09-20 | 2015-03-25 | Zeiss Carl Meditec Ag | Composition comprising at least one viscoelastic polymer |
| RS62909B1 (sr) | 2014-02-27 | 2022-03-31 | Synartro Ab | Konjugati hijalurona sa farmaceutski aktivnim supstancama, postupci i supstance |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2604930B2 (ja) * | 1990-12-14 | 1997-04-30 | 株式会社ディ・ディ・エス研究所 | ヒアルロン酸およびコンドロイチン誘導体 |
| CA2087452A1 (en) * | 1991-05-20 | 1992-11-21 | Toshiro Tsuda | Steriod compound combined with polysaccharide |
| JPH0616702A (ja) * | 1992-04-21 | 1994-01-25 | Shiseido Co Ltd | 修飾ヒアルロン酸、その製造方法及びそれを用いた徐放化製剤 |
-
1995
- 1995-05-10 IT IT95PD000089A patent/IT1281876B1/it active IP Right Grant
-
1996
- 1996-05-08 AU AU58945/96A patent/AU5894596A/en not_active Abandoned
- 1996-05-08 WO PCT/EP1996/001980 patent/WO1996035721A1/en active Application Filing
Also Published As
| Publication number | Publication date |
|---|---|
| ITPD950089A1 (it) | 1996-11-10 |
| ITPD950089A0 (it) | 1995-05-10 |
| AU5894596A (en) | 1996-11-29 |
| WO1996035721A1 (en) | 1996-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IT1281876B1 (it) | Acido ialuronico e suoi derivati esterei per la preparazione di matrici per il rilascio controllato di farmaci. | |
| AU8009998A (en) | Method for producing orally administered, solid pharmaceutical products with controlled release of the active substance | |
| MX9206541A (es) | Derivados de acido acetico, procedimiento para su preparacion y composicion farmaceutica que los contiene. | |
| MX9205168A (es) | Derivados de esteres azabiciclicos fusionados y procedimiento para su preparacion. | |
| FR2683146B1 (fr) | Compositions pharmaceutiques a liberation reglee de la substance medicamenteuse. | |
| AU5740996A (en) | Method for drug delivery to the pulmonary system | |
| EE9800065A (et) | 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks | |
| MX9202281A (es) | Derivados de benzofurano y procedimiento para su preparacion. | |
| ITMI951020A0 (it) | Derivati di diarildiammine | |
| MX9202022A (es) | Derivados de pirazina y proceso para su preparacion. | |
| ITMI962406A0 (it) | Procedimento per la preparazione di derivati cefalosporanici | |
| ITTO930346A0 (it) | Procedimento per la preparazione di derivati taurocolanici. | |
| EE9800109A (et) | 5-O-desosaminüül-6-O-metüülerütronoliid A uued derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete produktide valmistamiseks | |
| AU3699293A (en) | Stabilized solid pharmaceutical preparation and method of producing the same | |
| MX9207620A (es) | Derivados de bencenmetanamina a-substituidos y procedimiento para su preparacion. | |
| PL327173A1 (en) | Phospholipidic derivatives of phosphonocarboxylic acids, method of obtaining such derivatives and their application as antiviral drugs | |
| MX9203836A (es) | Derivados de acido-4-amino-3-hidroxicarboxilico y proceso para su preparacion. | |
| FI972949A (fi) | Lääkemuoto kollagenaasin vapauttamiseksi haavoihin ja sen valmistusmenetelmiä | |
| AU1104392A (en) | Method for the treatment of hepatic failure and disease | |
| FI942581A0 (fi) | Menetelmä 5-bromi-6-metoksi-1-naftoehappometyyliesterin valmistamiseksi | |
| MA22880A1 (fr) | Procede de preparation de produits pharmaceutiques . | |
| MX9204109A (es) | Derivados de acido 2-(imidazol-1-il)-2-bencil-etiliden-aminoxialcanoico y proceso para su preparacion. | |
| ITMI950469A0 (it) | Procedimento di produzione di derivati magnesiaci | |
| ITMI940023A0 (it) | Metodo per la preparazione di acido s-(+)- etodolico e di suoi derivati salini | |
| ATE223914T1 (de) | Trans apovincaminsäure-esterderivate als arzneimittel |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 0001 | Granted |